Benefits of Apixaban over Warfarin are Consistent, Irrespective of TTR

Summary

The results of a subanalysis of data from ARISTOTLE, demonstrated that the benefit of apixaban over warfarin was not related to the quality of INR control at the individual ARISTOTLE study centers.

  • Cardiology Clinical Trials
  • Cerebrovascular Disease
  • Arrhythmias
View Full Text